Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex

Psychiatry Research - Neuroimaging

Volumn 191, Issue 3, 2011, Pages 153-159

  Kosel, Markus ^a   Brockmann, Holger ^a   Frick, Caroline ^a   Zobel, Astrid ^a   Schlaepfer, Thomas E ^a,b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Dorsolateral prefrontal cortex; SPECT; Treatment resistant depression; VNS

Indexed keywords

ANTIDEPRESSANT AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; TECHNETIUM 99M;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL ARTICLE; FEMALE; HAMILTON SCALE; HUMAN; INSULA; LINGUAL GYRUS; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; PATIENT SAFETY; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGIONAL BLOOD FLOW; TECHNETIUM TC 99M EXAMETAZIME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 79951851593     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.11.004     Document Type: Article

References (37)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM IV) 1994, American Psychiatric Association, Washington, DC.
2. Bewernick B.H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., Axmacher N., Lemke M., Cooper-Mahkorn D., Cohen M.X., Brockmann H., Lenartz D., Sturm V., Schlaepfer T.E. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry 2010, 67:110-116.
3. Conway C.R., Sheline Y.I., Chibnall J.T., George M.S., Fletcher J.W., Mintun M.A. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research 2006, 146:179-184.
4. Daban C., Martinez-Aran A., Cruz N., Vieta E. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. Journal of Affective Disorders 2008, 110:1-15.
5. Dougherty D.D., Rauch S.L. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. The Psychiatric Clinics of North America 2007, 30:91-103.
6. Drevets W.C., Price J., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure & Function 2008, 213:93-118.
7. VNS premarket approval application 2003, Food and Drug Administration, Retrieved 04/15, 2010. http://www.accessdata.fda.gov/cdrh_docs/pdf/p970003s050a.pdf.
8. Friston K., Holmes A., Worsley K., Poline J., Frith C., Frackowiak R. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995, 2:189-210.
9. George M.S., Sackeim H.A., Rush A.J., Marangell L.B., Nahas Z., Husain M.M., Lisanby S.H., Burt T., Goldman J., Ballenger J.C. Vagus nerve stimulation: a new tool for brain research and therapy. Biological Psychiatry 2000, 47:287-295.
10. George M.S., Nahas Z., Lisanby S.H., Schlaepfer T., Kozel F.A., Greenberg B.D. Transcranial magnetic stimulation. Neurosurgery Clinics of North America 2003, 14:283-301.
11. Hamilton M. Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 1967, 6:278-296.
12. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American Journal of Psychiatry 2007, 164:778-788.
13. Kimbrell T.A., Little J.T., Dunn R.T., Frye M.A., Greenberg B.D., Wassermann E.M., Repella J.D., Danielson A.L., Willis M.W., Benson B.E., Speer A.M., Osuch E., George M.S., Post R.M. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry 1999, 46:1603-1613.
14. Kosel M., Schlaepfer T.E. Beyond the treatment of epilepsy: new applications of vagus nerve stimulation (VNS) in psychiatry. CNS Spectrums 2003, 8:515-521.
15. Lomarev M.P., Denslow S., Nahas Z., Chae J.H., George M.S., Bohning D.E. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. Journal of Psychiatric Research 2002, 36:219-227.
16. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry 2008, 64:461-467.
17. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003, 65:193-207.
18. Mu Q., Bohning D.E., Nahas Z., Walker J., Anderson B., Johnson K.A., Denslow S., Lomarev M., Moghadam P., Chae J.H., George M.S. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biological Psychiatry 2004, 55:816-825.
19. Nahas Z., Teneback C., Chae J.H., Mu Q., Molnar C., Kozel F.A., Walker J., Anderson B., Koola J., Kose S., Lomarev M., Bohning D.E., George M.S. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology 2007, 32:1649-1660.
20. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., George M.S., Charney D.S., Brannan S.K. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006, 31:1345-1355.
21. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C.C., Sackeim H.A., Mann J.J. Decreased regional brain metabolism after ECT. The American Journal of Psychiatry 2001, 158:305-308.
22. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., Demitrack M.A., George M.S., Sackeim H.A. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological Psychiatry 2007, 62:1208-1216.
23. Pardo J.V., Sheikh S.A., Schwindt G.C., Lee J.T., Kuskowski M.A., Surerus C., Lewis S.M., Abuzzahab F.S., Adson D.E., Rittberg B.R. Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage 2008, 42:879-889.
24. Prudic J., Sackeim H.A., Devanand D.P. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Research 1990, 31:287-296.
25. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience 2007, 10:1116-1124.
26. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., Howland R., Kling M.A., Rittberg B.R., Burke W.J., Rapaport M.H., Zajecka J., Nierenberg A.A., Husain M.M., Ginsberg D., Cooke R.G. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biological Psychiatry 2005, 58:347-354.
27. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., Johnson C.R., Seidman S., Giller C., Haines S., Simpson R.K., Goodman R.R. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713-728.
28. Schatzberg A.F., Kraemer H.C. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biological Psychiatry 2000, 47:736-744.
29. Schlaepfer T.E., Kosel M. Novel physical treatments for major depression: vagus nerve stimulation, transcranial magnetic stimulation and magnetic seizure therapy. Current Opinion in Psychiatry 2004, 17:15-20.
30. Schlaepfer T.E., Frick C., Zobel A., Maier W., Heuser I., Bajbouj M., O'Keane V., Corcoran C., Adolfsson R., Trimble M., Rau H., Hoff H.J., Padberg F., Muller-Siecheneder F., Audenaert K., Van den Abbeele D., Matthews K., Christmas D., Stanga Z., Hasdemir M. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine 2008, 38:651-661.
31. Schlaepfer T.E., George M.S., Mayberg H. WFSBP guidelines on brain stimulation treatments in psychiatry. The World Journal of Biological Psychiatry 2010, 11:2-18.
32. Schutter D.J. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine 2008, 39:65-75.
33. Speer A.M., Kimbrell T.A., Wassermann E.M., Repella J.D., Willis M.W., Herscovitch P., Post R.M. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry 2000, 4:1133-1141.
34. Tatsch K., Asenbaum S., Bartenstein P., Catafau A., Halldin C., Pilowsky L.S., Pupi A. European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging 2002, 29:36-42.
35. Van Laere K., Vonck K., Boon P., Brans B., Vandekerckhove T., Dierckx R. Vagus nerve stimulation in refractory epilepsy: SPECT activation study. Journal of Nuclear Medicine 2000, 41:1145-1154.
36. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Journal of Postgraduate Medicine 2002, 48:206-208.
37. Zobel A., Joe A., Freymann N., Clusmann H., Schramm J., Reinhardt M., Biersack H.J., Maier W., Broich K. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Research: Neuroimaging 2005, 139:165-179.